Marker Therapeutics, Inc. (MRKR) Social Stream



Marker Therapeutics, Inc. (MRKR): $4.32

0.17 (-3.79%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add MRKR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#89 of 359

in industry

MARKER THERAPEUTICS INC (MRKR) Price Targets From Analysts

Use the tables below to see what analysts covering MARKER THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 4 $8 $5.5 $6.375 $4.96 28.53%
2022-02-04 4 $8 $3 $5.625 $4.96 13.41%
2022-02-23 4 $6 $1 $4 $4.96 -19.35%
2022-03-18 4 $5 $1 $3.75 $4.96 -24.4%
2022-05-13 4 $5 $1 $3.625 $4.96 -26.92%
2022-05-16 1 $40 $40 $40 $4.96 706.45%
2022-08-11 4 $5 $1 $2.875 $4.96 -42.04%
2022-11-10 3 $4 $1 $2.166 $4.96 -56.33%

Price Target Last Issued May 16, 2022

The Trend in the Analyst Price Target


MRKR's average price target has moved down $4 over the prior 19 months.

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential

MRKR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 1 0 1 0 0 2

The Trend in the Broker Recommendations


Over the past 13 months, MRKR's average broker recommendation rating improved by 0.08.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MRKR as an investment opportunity.

  • MRKR has a greater average analyst price target than 71.55% of all US stocks.
  • MRKR has a higher upside potential (average analyst target price relative to current price) than 171.29% of stocks in the small market cap category.
  • MRKR has a greater number of analysts covering the stock than 125.22% of Healthcare stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, MARKER THERAPEUTICS INC's variance in analysts' estimates is lower than -656.33% of them.

Stocks similar to MARKER THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SYBX, ACRS, and ALPN.

Make investment decisions regarding MRKR using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!